Literature DB >> 27408069

Lymphoreticular Involvement in Human Immunodeficiency Virus Infection.

Mps Sawhney1.   

Abstract

BACKGROUND: Although lymphadenopathy, hepatomegaly and splenomegaly are commonly seen in human immunodeficiency virus (HIV) infection, little is known about the prognostic significance of these findings.
METHOD: A retrospective study of lymphoreticular involvement in 612 HIV-positive patients was done. RESULT: Lymphadenopathy was found in 301 (49.18%), hepatomegaly in 102 (16.66%) and splenomegaly in 58 (9.47%) patients. Sixty eight (32.54%) of the 209 patients with only lymphadenopathy had acquired immunodeficiency syndrome (AIDS), as compared to 70 (23.97%) of the 292 patients without lymphadenopathy or hepatosplenomegaly (χ(2) 4.49, df-1, p<0.05). There was a higher chance of having AIDS if hepatomegaly was present with lymphadenopathy. Eight (72.73%) of 11 patients with hepatomegaly alone, had AIDS. Thirty (68.18%) of 44 cases with splenomegaly, with lymphadenopathy and hepatomegaly, three (50%) of six cases having splenomegaly with lymphadenopathy and one (33.33%) of three cases with splenomegaly had AIDS. Majority of lymphoreticular involvement cases were due to Mycobacterium tuberculosis infection. All 29 cases with abdominal lymphadenopathy and one with hilar lymphadenopathy had AIDS. Bilateral discrete cervical, axillary and inguinal lymphadenopathy was the most common presentation. CD4 counts were significantly (p<0.05) lower in those with lymphadenopathy and hepatosplenomegaly.
CONCLUSION: HIV cases with lymphadenopathy and hepatomegaly should be investigated for the presence of opportunistic infection.

Entities:  

Keywords:  Hepatomegaly; Human Immunodeficiency Virus; Lymphadenopathy; Splenomegaly

Year:  2011        PMID: 27408069      PMCID: PMC4921746          DOI: 10.1016/S0377-1237(08)80135-9

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  9 in total

1.  Abdominal CT features and survival in acquired immunodeficiency.

Authors:  F D Knollmann; J Mäurer; T Grünewald; H Schedel; T J Vogl; H D Pohle; R Felix
Journal:  Acta Radiol       Date:  1997-11       Impact factor: 1.990

2.  [Ultrasonographic data of the solid organs of the abdomen in stage IV human immunodeficiency virus infection. A prospective study of 101 cases in central Africa].

Authors:  P Aubry; J P Reynaud; C Nbonyingingo; E Ndabaneze; E Mucikere
Journal:  Ann Gastroenterol Hepatol (Paris)       Date:  1994 Mar-Apr

3.  Tuberculous lymphadenitis, a diagnostic problem in areas of high prevalence of HIV and tuberculosis.

Authors:  H J Bekedam; M Boeree; A Kamenya; G Liomba; B Ngwira; V R Subramanyam; A D Harries
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 May-Jun       Impact factor: 2.184

4.  Prevalence and clinical significance of splenomegaly in asymptomatic human immunodeficiency virus type 1-infected adults. Swiss HIV cohort study.

Authors:  H Furrer
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079

5.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

Authors:  M C Raviglione; D E Snider; A Kochi
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

Review 6.  HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment.

Authors:  M C Raviglione; J P Narain; A Kochi
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

7.  Persistent lymphadenopathies in people at high risk for HIV infection. Clinicopathologic correlations and long-term follow-up in 79 cases.

Authors:  H L Ioachim; W Cronin; M Roy; M Maya
Journal:  Am J Clin Pathol       Date:  1990-02       Impact factor: 2.493

Review 8.  Tuberculosis and AIDS.

Authors:  F A Drobniewski; A L Pozniak; A H Uttley
Journal:  J Med Microbiol       Date:  1995-08       Impact factor: 2.472

9.  An audit of HIV testing and HIV serostatus in tuberculosis patients, Blantyre, Malawi.

Authors:  A D Harries; D Maher; B Mvula; D Nyangulu
Journal:  Tuber Lung Dis       Date:  1995-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.